Description

Tesamorelin

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue studied within endocrine and metabolic research. In the scientific literature, tesamorelin has been investigated for its interactions with growth hormone regulatory pathways and pituitary signalling mechanisms. Current research has explored its role across in vitro and preclinical models, examining endocrine modulation, metabolic processes, and hormone-mediated cellular pathways.

Manufactured to high analytical standards, this compound is supplied as lyophilised powder for laboratory research and analytical applications.

Purity: ≥99% (HPLC)
Form: Lyophilised Powder
Quantity: 5mg per vial
Molecular Weight: 5135.90 g/mol
CAS: 218949-48-5
Research: PubMed

Handling and Storage: Store in a cool, dry environment away from direct light. For long-term stability, the product should be stored refrigerated at 2°C to 8°C. Avoid repeated freeze-thaw cycles and exposure to moisture.

Regulatory Notice: Laboratory Research Use Only. This product is supplied strictly for in vitro laboratory research, analytical, or educational purposes only. Not for human or veterinary use, consumption, therapeutic application, or diagnostic purposes.

Certificates of Analysis and HPLC test results (internal and ISO 17025-accredited third-party) available on request to qualified researchers and clinicians, subject to credential verification. Please include institutional affiliation and intended use with your request.